Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer
26355.0000 -55.00 (-0.21%)
NSE Feb 26, 2026 15:31 PM
Volume: 1,908
 

logo
Abbott India Ltd.
13 Feb 2026
26355.00
-0.21%
ICICI Direct
New introduction tempo also maintained- Overall growth continues to be driven by legacy power brands (top 10 brands CAGR ~10% between January 23-26 despite slowdown in Mixtard and Novomix) and traction in few brands from the marketed portfolio. The company remains a standout performer among MNCs on the back of new products launch trajectory (+100 launches in the last 12 years and another 75 planned for the next 5 years) and performance consistency in most of the legacy brands. In FY25, the company introduced 7 new brands- Citrosoda UTI, Digene Insta,...
Abbott India Ltd. is trading below all available SMAs
More from Abbott India Ltd.
Recommended